Norton Cancer Institute, St Matthews Campus
Louisville, Kentucky, United States
Oncologist in St. Matthews, Kentucky
3991 Dutchmans Ln Suite 405, Louisville, KY 40207
About Norton Cancer Institute, St Matthews Campus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
ADC Therapeutics S.A.
2
Gilead Sciences
2
Merck Sharp & Dohme LLC
2
Astellas Pharma Inc
1
BeiGene
1
Chimerix
1
Constellation Pharmaceuticals
1
Helsinn Healthcare SA
1
Hoffmann-La Roche
1
Karyopharm Therapeutics Inc
1
Clinical Trials at Norton Cancer Institute, St Matthews Campus
During the past decade, Norton Cancer Institute, St Matthews Campus conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 3 clinical trials were completed. i.e. 23.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)
2015-12-21
2022-07-12
Completed
566
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
2017-06-23
2020-08-20
Terminated
406
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
2017-10-08
2025-05-31
Active, not recruiting
219
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
2017-12-19
2024-06-30
Active, not recruiting
1,550
NLA101 in Adults Receiving High Dose Chemotherapy for AML
2018-01-24
2019-03-18
Terminated
146
A Clinical Trial to Learn About the Study Medicine (Called TTI-622) Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma (MM)
2018-06-07
2026-06-17
Recruiting
476
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
2018-08-27
2023-12-31
Active, not recruiting
139
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
2018-12-01
2022-11-18
Terminated
136
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Norton Cancer Institute, St Matthews Campus" #1 sponsor was "Pfizer" with 3 trials, followed by "ADC Therapeutics S.A." with 2 trials
sponsored, "Gilead Sciences" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Astellas Pharma Inc"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Cancer Institute, St Matthews Campus"
#1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Norton Cancer Institute, St Matthews Campus
According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute, St Matthews Campus" are
"Acute Myeloid Leukemia" (4 trials), "Triple Negative Breast Cancer" (3 trials), "Carcinoma, Renal Cell" (2 trials), "Diffuse Large B-Cell Lymphoma" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Norton Cancer Institute, St Matthews Campus" in a lesser frequency.
Clinical Trials Intervention Types at Norton Cancer Institute, St Matthews Campus
Most popular intervention types in "Norton Cancer Institute, St Matthews Campus" are "Drug" (24 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (3 trials), "Placebo" (3 trials), "Belzutifan" (2 trials), "Carboplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Norton Cancer Institute, St Matthews Campus
The vast majority of trials in "Norton Cancer Institute, St Matthews Campus" are
23 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Norton Cancer Institute, St Matthews Campus
Currently, there are NaN active trials in "Norton Cancer Institute, St Matthews Campus".
undefined are not yet recruiting,
9 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Norton Cancer Institute, St Matthews Campus,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Norton Cancer Institute, St Matthews Campus, 7 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".